Search results for "From ACP Internist Weekly"
FIT may be useful for screening above-average-risk populations for colorectal cancer
A meta-analysis of 12 studies found that fecal immunochemical testing (FIT) may be a viable alternative screening strategy for patients at increased risk for colorectal cancer, but the authors and an accompanying editorial noted that the quality of the evidence was low.
https://gastroenterology.acponline.org/archives/2017/07/28/8.htm
28 Jul 2017
Mucosal healing an emerging goal of ulcerative colitis treatment, guideline states
The updated guideline from the American College of Gastroenterology offers recommendations on drug treatment and cancer screening, among other topics.
https://gastroenterology.acponline.org/archives/2019/03/22/8.htm
22 Mar 2019
Gastric bypass benefits persist over long-term follow-up, study finds
The authors said their study shows long-term durability of weight loss after bariatric surgery with Roux-en-Y gastric bypass, as well as related improvements in type 2 diabetes, hypertension, and lipid levels.
https://gastroenterology.acponline.org/archives/2017/10/27/7.htm
27 Oct 2017
Mailing fecal immunochemical tests to patients due for colorectal cancer screening increased screening uptake
Compared with usual care clinics, intervention clinics had a significantly higher adjusted clinic-level proportion of participants who completed a mailed fecal immunochemical test and more participants who completed any colorectal cancer screening.
https://gastroenterology.acponline.org/archives/2018/08/24/8.htm
24 Aug 2018
ACP issues new guidance on colorectal cancer screening
For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
https://gastroenterology.acponline.org/archives/2019/11/22/8.htm
22 Nov 2019
FIT screening may not be the best method to find right-sided cancers, study indicates
An accompanying editorial noted that fecal immunochemical testing (FIT) may be less effective in the right colon in part because lesions grow more rapidly and bleed less.
https://gastroenterology.acponline.org/archives/2018/10/26/6.htm
26 Oct 2018
6-food elimination diet may work for more than half of patients with eosinophilic esophagitis
Removing milk, wheat, soy, eggs, tree nuts/peanuts, and fish/shellfish from one's diet and then gradually reintroducing these food categories identified a single food trigger for 69% of participating patients with eosinophilic esophagitis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2022/08/26/7.htm
26 Aug 2022
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
Use of PPIs associated with higher risk of death than use of H2 blockers
Study results should not deter prescription and use of proton pump inhibitors (PPIs) where medically indicated but rather emphasize the need to be judicious about use of PPIs and duration of therapy, the authors said.
https://gastroenterology.acponline.org/archives/2017/07/28/6.htm
28 Jul 2017
Regular use of PPIs linked to increased risk of type 2 diabetes
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://gastroenterology.acponline.org/archives/2020/10/23/7.htm
23 Oct 2020